These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins. Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256 [TBL] [Abstract][Full Text] [Related]
24. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. Kimura T; Sato K; Kuwabara A; Tomura H; Ishiwara M; Kobayashi I; Ui M; Okajima F J Biol Chem; 2001 Aug; 276(34):31780-5. PubMed ID: 11427538 [TBL] [Abstract][Full Text] [Related]
26. Ligand-receptor interaction in the specific targeting of biomimetic peptide nanoparticles to lysophosphatidylcholine. Wang A; Yue K; Zhong W; Zhang G; Wang L; Wang H; Zhang H; Zhang X Int J Biol Macromol; 2023 Feb; 227():193-202. PubMed ID: 36549027 [TBL] [Abstract][Full Text] [Related]
27. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia. Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748 [TBL] [Abstract][Full Text] [Related]
28. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Matsuda Y Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661 [TBL] [Abstract][Full Text] [Related]
29. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Kugiyama K; Sakamoto T; Misumi I; Sugiyama S; Ohgushi M; Ogawa H; Horiguchi M; Yasue H Circ Res; 1993 Aug; 73(2):335-43. PubMed ID: 8330376 [TBL] [Abstract][Full Text] [Related]
30. Metabolism and atherogenic disease association of lysophosphatidylcholine. Schmitz G; Ruebsaamen K Atherosclerosis; 2010 Jan; 208(1):10-8. PubMed ID: 19570538 [TBL] [Abstract][Full Text] [Related]
32. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1. Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407 [TBL] [Abstract][Full Text] [Related]
33. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074 [TBL] [Abstract][Full Text] [Related]
34. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress. Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173 [TBL] [Abstract][Full Text] [Related]
35. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Hoff HF; O'Neil J Arterioscler Thromb; 1991; 11(5):1209-22. PubMed ID: 1911707 [TBL] [Abstract][Full Text] [Related]
36. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457 [TBL] [Abstract][Full Text] [Related]